Industry 4.0 is all the rage amongst larger tissue producers and purports, amongst other things, to enable large-scale machine-to-machine communication such that individual manufacturing processes are no longer conducted in functional silos. Instead, holistic knowledge of all processes is to enable a continuous improvement cycle that drives different manufacturing performance measures, such as overall equipment effectiveness (OEE) to new levels, ultimately improving the enterprise’s earnings.
Unfortunately, production “silos” without cross process thinking still exist even in the most advanced facilities. It is, for example, not uncommon that the quality metric on most tissue machines is to get paper with correct weight, moisture and perhaps caliper onto the reel without a web break. Anything that gets reeled can be placed in the warehouse and/or passed to converting. Little to no concern is given to how the actual tissue surface quality might affect downstream converting operations. The calculated OEE, a multiple of the tissue machine’s availability, performance and quality of the product produced, will reflect an inflated value as the quality measure will be positively skewed. Production looks great while potential problems are transferred downstream. It is no wonder then that most converting plant managers see tissue production as their primary enemy in meeting operational targets.

